135 related articles for article (PubMed ID: 11527686)
1. Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey.
Coiffier B; Guastalla JP; Pujade-Lauraine E; Bastit P;
Eur J Cancer; 2001 Sep; 37(13):1617-23. PubMed ID: 11527686
[TBL] [Abstract][Full Text] [Related]
2. Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.
Denison U; Baumann J; Peters-Engl C; Samonigg H; Krippl P; Lang A; Obermair A; Wagner H; Sevelda P
Breast Cancer Res Treat; 2003 Jun; 79(3):347-53. PubMed ID: 12846419
[TBL] [Abstract][Full Text] [Related]
3. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
[TBL] [Abstract][Full Text] [Related]
4. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey.
Steurer M; Wagner H; Gastl G
Wien Klin Wochenschr; 2004 Jun; 116(11-12):367-72. PubMed ID: 15291288
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
7. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
Schouwink JH; Codrington H; Sleeboom HP; Kerkhofs LG; Wormhoudt LW
Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652
[TBL] [Abstract][Full Text] [Related]
8. Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.
Savonije JH; van Groeningen CJ; van Bochove A; Honkoop AH; van Felius CL; Wormhoudt LW; Giaccone G
Eur J Cancer; 2005 Jul; 41(11):1560-9. PubMed ID: 15953714
[TBL] [Abstract][Full Text] [Related]
9. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy.
Barrett-Lee PJ; Bailey NP; O'Brien ME; Wager E
Br J Cancer; 2000 Jan; 82(1):93-7. PubMed ID: 10638973
[TBL] [Abstract][Full Text] [Related]
10. RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy.
Eisterer W; Hussl C; Erb H; Haslbauer F; Sormann S; Braun S; Jaeger C
Curr Med Res Opin; 2011 Feb; 27(2):355-63. PubMed ID: 21166611
[TBL] [Abstract][Full Text] [Related]
11. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
12. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer.
Thatcher N; De Campos ES; Bell DR; Steward WP; Varghese G; Morant R; Vansteenkiste JF; Rosso R; Ewers SB; Sundal E; Schatzmann E; Stocker H
Br J Cancer; 1999 May; 80(3-4):396-402. PubMed ID: 10408844
[TBL] [Abstract][Full Text] [Related]
13. A retrospective review of blood transfusions in cancer patients with anemia.
Estrin JT; Schocket L; Kregenow R; Henry DH
Oncologist; 1999; 4(4):318-24. PubMed ID: 10476543
[TBL] [Abstract][Full Text] [Related]
14. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
Kosmidis P; Krzakowski M;
Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
[TBL] [Abstract][Full Text] [Related]
15. Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.
Boogaerts M; Oberhoff C; Ten Bokkel Huinink W; Nowrousian MR; Hayward CR; Burger HU
Anticancer Res; 2006; 26(1B):479-84. PubMed ID: 16739308
[TBL] [Abstract][Full Text] [Related]
16. A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice.
Van Belle S; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Aerts JG
Curr Med Res Opin; 2012 Jul; 28(7):1079-87. PubMed ID: 22642867
[TBL] [Abstract][Full Text] [Related]
17. Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.
Cheer SM; Wagstaff AJ
Drugs; 2004; 64(3):323-46. PubMed ID: 14871172
[TBL] [Abstract][Full Text] [Related]
18. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
19. Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.
Glaspy J; Degos L; Dicato M; Demetri GD
Oncologist; 2002; 7(2):126-35. PubMed ID: 11961196
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.
Birgegård G; Gascón P; Ludwig H
Eur J Haematol; 2006 Nov; 77(5):378-86. PubMed ID: 17044835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
